Genetic Abnormalities of Lung Cancer

Genetic mutations that are known to play critical roles in the development and progression of NSCLC include:

 

 

 

 

  •  Epidermal growth factor receptor (EGFR) – the EGFR gene is responsible for a protein that helps a cell respond to its environment and can trigger cell growth, division, and survival.
  •  KRAS – the KRAS gene is involved in regulating cell division.
  •  Anaplastic lymphoma kinase (ALK) – the ALK gene provides instructions for a protein that plays an important role in cell growth, division, and maturation.

 

  • Epidermal Growth Factor Receptor (EGFR)
  • Kirsten RAS (KRAS)
  • Anaplastic Lymphoma Kinase (ALK)
  • Other Genetic Abnormalities in NSCLC

Related Conference of Genetic Abnormalities of Lung Cancer

November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 24-25, 2026

6th International Conference on Oncology and Cancer

Paris, France
December 03-04, 2026

10th Global Meeting on Oncology and Radiology

Madrid, Spain
December 08-09, 2026

27th World Congress on Cancer Summit

Paris, France
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France
February 15-16, 2027

5th World Congress on Oral Cancer

Singapore City, Singapore
April 15-16, 2027

12th World Conference on Breast and Cervical Cancer

Amsterdam, Netherlands
April 26-27, 2027

26th World Congress on Cancer and Diagnostics

Barcelona, Spain
April 27-28, 2027

37th Experts Meet On Cancer Research & Therapy

Paris, France
May 05-06, 2027

7th World Congress on Breast Cancer

Berlin, Germany
May 05-06, 2027

23rd International Conference on Cancer Research

Berlin, Germany

Genetic Abnormalities of Lung Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in